CBO Revises Orphan Drug Cost Estimate to $8.8 Billion: Implications for Pharma & Healthcare Spending
October 20, 2025
The Congressional Budget Office (CBO) made headlines with its recent announcement about
- May 23, 2026
Digital therapeutics, apps, and health technology
The Congressional Budget Office (CBO) made headlines with its recent announcement about
The biopharmaceutical landscape is on the cusp of a technological revolution, with
The biopharma landscape is constantly evolving, with a growing focus on innovative
Roche’s investigational drug giredestrant is carving a niche for itself in the
In the fast-paced world of biopharma, staying informed about the latest trends
In a significant shift within the biopharmaceutical landscape, I-Mab Biopharma has officially
In a groundbreaking move that could reshape the landscape of rare disease
Roche continues to solidify its position as a leader in oncology with
Praxis Precision Medicines has experienced a remarkable surge in share value, soaring
In a significant move to alleviate the financial burden of diabetes management,
In a promising development for the biopharma industry, EVOQ Therapeutics, headquartered in
In a significant move within the biopharmaceutical landscape, Novo Nordisk has secured
Navigating the complex landscape of FDA regulations can be daunting for biopharmaceutical
In a significant development for the biopharma industry, Tubulis, a biotech company
In a transformative move for the biotech industry, AstraZeneca has made headlines
Pfizer has recently made headlines with the promising results of their drug,
In a rapidly evolving healthcare landscape, the intersection of technology and patient
Excellergy, an innovative biotech company located in the San Francisco Bay Area,
In a significant development within the pharmaceutical industry, the U.S. Food and
In a significant breakthrough for the biopharma industry, Regeneron Pharmaceuticals is making
